Published in Vopr Onkol on January 01, 1976
[Effect of fenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats]. Vopr Onkol (1980) 0.87
[Inhibition of the blastomogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, diphenin, a polypeptide pineal extract and L-DOPA]. Biull Eksp Biol Med (1980) 0.80
[Increase in longevity and a decrease in the frequency of tumors in C3H/Sn mice under the influence of fenformin and diphenin]. Dokl Akad Nauk SSSR (1979) 0.79
[Phenformin elimination of the immunodepression caused by 1,2-dimethylhydrazine in rats]. Vopr Onkol (1977) 0.79
[An increase in hypothalamic sensitivity to the inhibiting effects of estrogens caused by use of L-DOPA, diphenine, epithalamin and phenformin in old rats]. Biull Eksp Biol Med (1975) 0.78
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77
Increase with age in the hypothalamo-hypophyseal threshold to the inhibitory action of estrogens and the effect of pineal extract on this process. Bull Exp Biol Med (1974) 0.76
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75
[Aging and cancer: the foundation of strategies of ontogenetic prophylaxis]. Eksp Onkol (1989) 0.75
[Inhibition of growth, fat-mobilization and lactogenic effects of somatotropic hormone with antiserum to anahormone of human placental lactogen]. Biull Eksp Biol Med (1972) 0.75
Age increase in cholesterol content of peripheral blood lymphocytes. Hum Physiol (1981) 0.75
[Age associated factor in the risk of tumor development]. Vopr Onkol (1973) 0.75
[The effect of pharmacological preparations on the regulation of growth hormone secretion]. Probl Endokrinol (Mosk) (1994) 0.75
[Dexamethasone test, somatomedin level and other metabolic indices in adenoma and cancer of the prostate]. Vopr Onkol (1983) 0.75
[Detection of antibodies to adipose tissue cell membranes in human blood]. Biull Eksp Biol Med (1991) 0.75
[Somatomedin activity of the blood: hormonal metabolic and immunological shifts in cancer patients]. Vopr Onkol (1988) 0.75
[Resistance of the inhibition of the growth hormone and fatty acids by glucose in patients with cancer of the breast and uterine body]. Vopr Onkol (1971) 0.75
[Prognosis of breast cancer patients with large-fetus birth weights in their history]. Vopr Onkol (1981) 0.75
[Immunocorrective therapy in esophageal cancer]. Vopr Onkol (1987) 0.75
[Improvement of the indicators of cellular immunity under the effect of polypeptide epiphyseal extract (epithalamine)]. Vopr Onkol (1977) 0.75
[A model of hypoparathyroidism induced by antibodies to active parathormone and its anahormone]. Patol Fiziol Eksp Ter (1972) 0.75
[Comparison of the anti-tumor activity of extracts of the epiphysis and hypothalamus, melatonin and sigetin in mice with transplanted mammary gland cancer]. Vopr Onkol (1973) 0.75
[Cutaneous fat fold thickness, obesity characteristics and body surface in breast cancer and fibroadenomatosis]. Vopr Onkol (1979) 0.75
Suppressive effect of estrogens on mobilization of free fatty acids by growth hormone. Fed Proc Transl Suppl (1966) 0.75
[Anahormone-chimeras. Hormonally-inactive conjugate of bovine ACTH and human somatotropin, retaining the antigenic properties of the original hormones]. Dokl Akad Nauk SSSR (1972) 0.75
[On the criticism of antitumor immunity: arguments for and against]. Vopr Onkol (1988) 0.75
[Carcinogenic aging]. Vestn Akad Med Nauk SSSR (1980) 0.75
[Influence of miskleron (clofibrate) on the carcinogenic effect of 7,12-dimethylbenz(alpha)anthracene and nitrosomethylurea in female rats]. Vopr Onkol (1981) 0.75
[Thymic involution in mice induced by excess sugar and saturated fat in the dietary ration]. Dokl Akad Nauk SSSR (1991) 0.75
[Production of iodine-131 labelled melanocyte stimulating hormone and its distribution in mice with melanoma]. Vopr Onkol (1970) 0.75
[Effect of phenformin on fetal mass in rats previously immunized with an extract of homologous thyroid gland]. Biull Eksp Biol Med (1981) 0.75
[Inhibition of the hypocalcemic effect of thyrocalcitonin by its acetylated derivative]. Dokl Akad Nauk SSSR (1971) 0.75
[Inhibition of the adrenal gland function by acetylated derivatives of adrenocorticotropic hormone]. Biull Eksp Biol Med (1970) 0.75
[Age and increase in the sensitivity threshold of the tonic region of the hypothalamic sex center to inhibition by estradiol in female rats]. Biull Eksp Biol Med (1978) 0.75
[Body weight, blood lipids, blood cortisol and prognosis of patients with cancer of the large intestine and breast]. Vopr Onkol (1989) 0.75
[Urgent problems of endocrinological oncology]. Vopr Onkol (1979) 0.75
[Genetic-metabolic model of cancer cell behavior]. Vopr Onkol (1980) 0.75
[Study of the action of lipotropic hormone and its derivatives on rabbits: development of resistance, separation of the fat-mobilizing and hypocalcemic effects, and its effect on carbohydrate metabolism]. Probl Endokrinol (Mosk) (1975) 0.75
[Decrease in the excretion of antigonadotropic factor in patients with cancer of the uterine cervix and prostate gland. Experimental antitumor effect of an epiphyseal extract]. Vopr Onkol (1976) 0.75
[Birth weight and growth of children-cancer patients]. Pediatriia (1977) 0.75
[Effect of miskleron (clofibrate) on dimethylhydrazine induction of intestinal tumors in rats]. Biull Eksp Biol Med (1980) 0.75
[Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms]. Vopr Onkol (1972) 0.75
[Comparison of metabolic and immunologic indices in breast cancer]. Vopr Onkol (1980) 0.75
[Evaluation of the function of the hypothalamo-hypophyseal complex and gonads of patients with prostatic adenoma and cancer using the dexamethasone test]. Urol Nefrol (Mosk) (1984) 0.75
Age dynamics of regulation in the adaptation homeostat and age pathology. Hum Physiol (1979) 0.75
[Insulin sensitivity in colon, lung and uterine cancer]. Vopr Onkol (1973) 0.75
[Carcinoembryonic antigen in the blood in the process of correcting carbohydrate metabolic disorders in patients with gastrointestinal cancer]. Med Radiol (Mosk) (1983) 0.75
[The relation of a number of hormonal indices to risk factors for IHD and its prevalence based on the data from a large population study]. Ter Arkh (1995) 0.75
[Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Ectopic production of hormones and embryonic proteins by stimulated human lymphocytes]. Dokl Akad Nauk SSSR (1985) 0.75
[Expression of proto-oncogenes myc and ras and hormonal regulation of adenylate cyclase in human colon tumor cells]. Dokl Akad Nauk SSSR (1989) 0.75
[The immunologic and hormonal activity of chorionic gonadotropin in patients with trophoblastic disease]. Vopr Onkol (1970) 0.75
[Inhibition of the growth of Ehrlich transplantable carcinoma in mice by antichorionic immune serum]. Vopr Onkol (1983) 0.75
Correlation between DNA repair and cholesterol concentration in blood serum and lymphocytes. Hum Physiol (1981) 0.75
[Study of the age dynamics of a metabolic and immune complex of indicators by the technic of statusometry]. Fiziol Cheloveka (1987) 0.75
[Endocrine changes in children with acute viral hepatitis]. Probl Endokrinol (Mosk) (1988) 0.75
[Inhibition of the hypercalcemic effect of endogenous parathyroid hormone by its azo derivative in the EDTA test]. Vopr Med Khim (1972) 0.75
[Inactivation of the biological action of estrogens and growth hormone by antibodies to the hormonally inactive conjugate of human somatotriopin and estrone]. Biull Eksp Biol Med (1973) 0.75
[Approaches to the study of hormone dependent tumors (qualitative changes in hormone formation)]. Vestn Akad Med Nauk SSSR (1968) 0.75
[Raising the threshold of sensitivity of the hypothalalomo-hypophyseal system to the homeostatic action of estrogens under the influence of carcinogenic substances]. Vopr Onkol (1974) 0.75
[Increase in the sensitivity threshold of the hypothalamo-hypophyseal complex to the inhibiting action of dexamethasone in the process of aging and in cervical cancer]. Vopr Onkol (1979) 0.75
[Central mechanism of the action of 17-alpha-hydroxy-progesterone capronate in the treatment of endometrial cancer]. Akush Ginekol (Mosk) (1977) 0.75
[Endocrine changes in cancer of the rectum and colon]. Vopr Onkol (1987) 0.75
[Effect of pineal body extract on the sensitivity threshold of the hypothalamus to the inhibiting effect of prednisolone]. Vopr Onkol (1972) 0.75
[The effect of eliptene aminoglutethimide on the excretion of gonadotropins and phenol steroids (preliminary study)]. Vopr Onkol (1969) 0.75
[Overcoming artificial tolerance to somatotropin by a human somatotropin anahormone with additional antigenicity]. Biull Eksp Biol Med (1972) 0.75
[Study of the relationship between the function of the lymphocytes and monocytes and the level of various lipids and 11-hydroxycorticosteroids in diabetes mellitus]. Probl Endokrinol (Mosk) (1980) 0.75
[Effect of human serum lipoproteins on various indices of thyroid function in rats]. Probl Endokrinol (Mosk) (1982) 0.75
[Cyclic adenosine monophosphate content in the lymphocytes of cancer patients]. Eksp Onkol (1985) 0.75
[Distribution of I-131 labeled somatotropic and adrenocorticotropic hormones and their conjugates with alkylating compounds in rats]. Med Radiol (Mosk) (1972) 0.75
[Aromatase activity in lymphocytes of cancer patients and healthy subjects]. Vopr Onkol (1990) 0.75
[Depression of lipolysis and potentiation of the hypoglycemic effect of insulin using insulin derivatives with a neutral effect on the blood sugar level]. Probl Endokrinol (Mosk) (1973) 0.75
[Acetylated corticotropin suppression of age dependant increase in the weight of the ovaries in mice]. Vopr Onkol (1974) 0.75
[Correlation between immunological reactivity and the fat-carbohydrate metabolism. Influence of phenformin]. Vopr Onkol (1976) 0.75
[Hyperprolactinemia as a marker of the progression of cervical cancer]. Vopr Onkol (1990) 0.75
[Dialectics of the local and the general in understanding cancer as a disease]. Vopr Onkol (1983) 0.75
[Somatomedin activity in patients with malignant neoplasms]. Vopr Onkol (1988) 0.75
[Oncofactors (transforming growth factors)]. Vopr Onkol (1983) 0.75
[The different effects of estrogen and drugs suppressing ovulation on tolerance to carbohydrates]. Akush Ginekol (Mosk) (1972) 0.75
[Clinical importance of increased levels of the growth hormone in kidney diseases]. Klin Med (Mosk) (1980) 0.75
[Justification of the use of diphenine (diphenylhydantoin) in oncologic practice]. Vopr Onkol (1971) 0.75
[Anahormone of sheep luteinizing hormone inducing antibodies against human gonadotropin]. Biull Eksp Biol Med (1971) 0.75
[Capacity of rhabdomyosarcoma cells to produce substances with somatomedin and mitogenic activity]. Eksp Onkol (1988) 0.75
[Distribution of 131I-labelled growth hormone in mice of high and low cancer lines]. Vopr Onkol (1980) 0.75
[Effect of epiphyseal extracts in lowering the threshold sensitivity of the hypothalamo-hypophyseal system of old female rats to the action of estrogens]. Dokl Akad Nauk SSSR (1973) 0.75
[Cyclic adenosine monophosphate and prostaglandins in oncology]. Vopr Onkol (1974) 0.75
[Antibodies to thyroglobulin in patients with cancer]. Vopr Onkol (1977) 0.75
[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. Vopr Onkol (1980) 0.75
[Improvements in the methods of diagnosing and treating trophoblastic disease]. Vopr Onkol (1969) 0.75
[Control of the effectiveness of the hypolipidemic effects of miscleron and phenformin]. Klin Med (Mosk) (1991) 0.75
[Inhibition of the effect of exogenous parathyroid hormone by its azoderivative in parathyroidectomized rats]. Biull Eksp Biol Med (1971) 0.75
[Effect of succinic and glutamic acids on the sensitivity of the hypothalamo-gonadotropic system to inhibitory effect of estrogens in old rats]. Farmakol Toksikol (1977) 0.75
Transformation of the development program in the mechanism of age pathology. An elevational model of age pathology and natural death in man. Hum Physiol (1979) 0.75
[Supression of the lymphocyte blast transformation reaction evoked in human subjects by a fat load]. Vopr Onkol (1979) 0.75
[Inhibiting effect of phenformin (phenethyl biguanide) on the growth of Ehrlich carcinoma]. Vopr Onkol (1981) 0.75
[Biological action of antisera to somatotropin in humans]. Vopr Onkol (1971) 0.75